SlideShare a Scribd company logo
Presented by:
Yasmeen Mir
M. Pharm ist year
(Pharmacology-İII)
Roll no.:18155110001
Anxiety Disorders
 Definition : Anxiety is a condition of persistent
and uncontrollable nervousness, stress, and worry,
triggered by anticipation of future events,
memories of past events, or ruminations over day-
to-day events, with disproportionate fears of
catastrophic consequences.
 It is characterized by feelings of apprehension,
insecurity, uncertainty or fear.
 Generalized Anxiety Disorder(Excessive, unrealistic
worry that lasts six months or more)
 Obsessive-Compulsive Disorder (Persistent, recurring
thoughts or obsessions that reflect exaggerated anxiety
or fears )
 Post-Traumatic Stress Disorder ( Exposure to a
traumatic event)
Panic Disorders (Severe attacks of panic for no
apparent reason)
 Phobias (Extreme anxiety about being judged by
others, or intense fear reaction to a specific object or
situation such as spiders, dogs, or Acrophobia).
Types of anxiety
Preclinical anxiety models
 The goal of anxiety models is to produce a form of
abnormally elevated anxiety.
 It should more closely resemble, by definition, the
pathological nature of human anxiety disorders.
 Anxiety models are Models that generate lasting or
permanently heightened anxiety.
 This can be achieved by acutely or chronically subjecting
animals to stressors before testing.
 OR identifying genetic populations (inbred and selectively
bred strains) or engineering mutant mice with innate
anxiety-like phenotypes.
This approach has proven to be valuable for screening novel
anxiolytics and testing the pharmacoselectivity of putative anxiolytics .
Emerging genetic technology is the optogenetics. It will be integral to
future basic anxiety research.
optogenetics is the combination of genetic and optical methods to
control specific events in targeted cells of living tissue in the
millisecond timescale.
Optogenetic approaches have been used to map neural circuits in the
amygdala that contribute to fear conditioning.
PRECLINICAL EVALUATION OF
ANXIOLYTICS
In-vitro Methods:
1. GABA receptor binding
2. Benzodiazepine receptor: [3H]-flunitrazepam binding
assay
3. Serotonin (5-HT1A) receptor: binding of [3H]-8-hydroxy-
2-(di-n-propylamino)-tetralin ([3H]-DPAT)
4. Serotonin (5-HT1B) receptors in brain: binding of [3H]5-
hydroxytryptamine ([3H]5-HT)
The following parameters are calculated:
• Total binding
• Non-specific binding
•Specific binding= total binding– non-specific
binding.
 In Vivo Methods
 Methods based on unconditioned
(spontaneous) response:
 Exploratory activity
 Elevated plus-maze (other
Mazes such as Y, X,T, Radial, water
and Zero Maze)
 Open field/Closed field
 Light-dark model (two
compartment box)
 Staircase exploration
 Hole board test
 Mirror chamber test
 Social behavior
 Social interaction
 Isolation induced aggression
 Anticipatory anxiety in mice
 Predator
 Defense test battery in rats
 Human threat (Primates)
 Odor associated avoidance
behavior
 Others
 Novelty suppressed feeding
 Schedule induced polydipsia in
rats
 Marble burying
 Cork gnawing
 Stress induced hyperthermia
• Methods based on conditioned (learned) response:
Punishment models:
• Four plate test
• Punishment induced operant behavior
• Conditioned emotional response
Conflict models:
• Vogel punished drinking
• Geller seifter conflict (marmoset, pigeon conflict)
• Shock probe conflict procedure
Respondent conditioned with aversion stimuli:
• Conditioned suppression
• Potentiated startle response
• Electric brain stimulation
Frustration (non-reward) test:
• Shock probe- burying test
In Vivo Methods
Validity
• Face validity : A feature that is assessed (for a test or model of anxiety) by
determining how closely the model or test resembles human anxiety
symptoms.
• Predictive validity : whether the model or test reliably responds to clinically
efficacious anti- anxiety medications.
• Construct validity : whether the degree to which the model or test recruits
the same underlying neurobiology as implicated in human anxiety.
Elevated Plus Maze Test
For selective identification
of anxiolytics and anxiogenic
drugs
Anxiolytics –decrease
anxiety – increase open arm
exploration time.
Anxiogenics – decrease open
arm exploration time.
Most widely used method;
male mice/rats used.
Experimental Design
• Group I : control
• Group II : standard
• Group III : test treated with dose x
• Group IV : test treated with dose 2x ….
The rats weighing around 200g - housed in pairs
for 10 days prior to testing; 6animals selected for
each group.
Test drug administered 30min prior to
experimentation by i.p route.
The rat is then placed in the centre of the
maze facing one of the enclosed arms.
Animals were allowed to explore in the maze for 5
min. Observations will done from adjacent room via
remote TV camera.
Parameters Measured During Next 5 minutes:
o time spent in the open arms
o entries into the open arms
o time spent in the closed arms
o entries into the closed arms
o total arm entries
Evaluation of results:
o Motor activity and open arm exploratory activity determined.
o Values of treated groups expressed as % of control values.
o Benzodiazepines and valproate – decrease motor activity
increase exploratory time.
Anxiolytic effect indicated by:
o Increase in the proportion of time spent in open arms.
o Increase in the proportion of entries into open arms.
Open-field Test
 This test, originally designed by
Hall on rats.
 It consists of placing an animal
in an unknown environment
with surrounding walls, so as to
observe a number of behavior
patterns, including:
 The tendency to stay on the
periphery of the field without
entering the centre (called
thigmotaxis and often
interpreted as anxious behavior)
 level of defecation and
urination.
Anxiolytic agents should lead to increase in this ratio.
 The open field floor is divided into squares
 Animals are tested individually, always being placed in
the same position.
 Duration of test is usually 5 min.
Higher levels of anxiety should mainly lead to decreases
in the ratio ‘number of squares
visited in centre/number of squares visited on periphery.
Light – dark model
• Crawley and Goodwin
(1980).
• Mice and rats tend
to explore novel
environment ,but
retreat from
brightly- lit
open field.
In a two chambered system, where animal can freely move between brightly
lit open field and dark corner, they show more crossings between two
chambers and more locomotor activity after treatment with anxiolytics.
Methodology
• Test apparatus- light and dark chamber divided by photocell equipped zone.
• Polypropylene animal cage 44x21x21 cm, darkened with black spray over on-
third of surface.
• Partition containing 13cm long x 5cm high opening separates the dark one
third from bright two thirds of the cage
• Cage rests on an animex activity monitor, which counts the locomotor
activity.
• Four sets of photocells across the partition, automatically counts movement
through the partition and clocks time spent in light and dark
Male mice with a weight between 18 and 24 g are used
Test drug administered 30min prior to experimentation by
i.p. route.
The animal is placed in the cage and observed for
10 min.
Observation
o No. Of crossings through the partition between the light
and dark chambers compared with total activity counts
during the 10 min.
o Loco motor activity also monitored.
Evaluation:
o Anxiolytics like diazepam & buspirone increase locomotor
activity and no. Of crossings.
o Non anxiolytics - not effective in this model.
Staircase exploration
• When introduced into a novel environment, rodents
experience a conflict between anxiety and exploratory
behavior manifested by increased vigilance and behavioral
activity
• Staircase climibing reflects exploratory or locomotor
activity
• Rearing behavior is an index of anxiety state
• The no. of rearing and steps climbed to be recorded for
period of 5 minutes
• Decrease in rearing behavior and increase in steps climbed
is characterization of anxiolytic effect
Male mice (Charles River strain) with a weight
between 18 and 24 g are used
Test drug administered 30min prior to
experimentation by s.c. route.
The animal is placed on the floor of the box with
its back to the staircase.(staircase is composed of
five identical
steps 2.5 cm high, 10 cm wide )
Mirrored chamber test
Novel stimulation evokes both exploration and anxiety and therefore generates
approach avoidance conflict behaviour
• It is hypothesised that distortion of readily traversed environment by a chamber of
mirror might produce aversion to entry
• Mice are exposed to the chamber of mirror
• Extended latency to enter the chamber of mirror used as a parameter for anxiety
analogy
• Anxiolytics reduce this latency in dose dependent manner.
Social interaction in rats
• Purpose and rationale : In an
unfamiliar and brightly lit
environment, the normal social
interaction of rats ( sniffing,
nipping, grooming) is suppressed.
• Anxiolytics counteract this
suppression.
Animals placed in groups of 5 each in a perspex open
topped box
1hr before test,2 rats from separate housing treated
with test compound orally
Placed in box with 60W bulb and behavior observed
for 10minutes
social interactions like sniffing, rearing, crawling over
the partner are observed
Procedure:
• Male sprague-dawley rats (225-275g) are housed in groups of 5 animals
• Apparatus: perspex open-topped box (51x51x 20cm) with 17x17cm marked areas on the
floor.
• One hour prior to the test, 2 naïve rats from separate housing cages are treated with
test compound orally
• They are placed into the box (with 60W bright illumination 17cm above) and their
behaviour is observed over a 10 min period.
• 2 types of behaviour can be noted:
• Social interaction between the animals is determined by timing the sniffing of
partner, crawling under or climbing over partner and following partner.
• Exploratory motion is measured as the number of crossings of the lines marked on
the floor of the test box.
• Six pairs are used for each dose
• Evaluation: values of treated partners are compared with the data from 6 pairs of
untreated animals using single factor analysis of variance followed by Dunnett’s
test
Isolation induced aggression
o Male mice subjected to isolation
Develop aggressive behavior towards
other animals of same sex.
Male Mice kept isolated for 6weeks & aggressive behavior
tested.
Male mice accustomed to live together placed in cage of
isolated mice for 5minutes
Isolated mice attacks intruder aggressiveness observed
Drugs given to isolated mice s.c or orally; aggressive behavior
tested at 60, 120,240 minutes (oral route)
If drug active- decrease in aggressiveness Attenuation of
fighting reaction
Human threat (primates):
Suarez and Gallup (1982) first demonstrated human
being as a predator. It can be studied in various ways of
avoidance of experimenter. One method involves an
experimenter sitting in a chair in the center of a floor
containing chicks. The proximity of the chicks to the human
is then determined usually by numbering imaginary zones
around the occupied chair. The chicks are then given an
‘avoidance score’ of 1-5 (either in ascending or descending
proximity to the experimenter) based on a total of their
positions over a certain time frame. Another method is
called the ‘box plus experimenter’ method. This test uses
the same premise as the above method; however, during
the box plus experimenter test, the human is seated behind
a wire mesh wall at the end of an arena. The chick is
scored on its approach or avoidance to the experimenter
behaviors. Again, higher avoidance suggests higher fear
levels.
Odour associated avoidance behaviour:
The predatory odour avoidance model relies upon
the apparently innate fear that rodents have for the odor
of their natural predators, such as cats and foxes. Rats
tend to avoid such odors and engage in a variety of
defensive behaviours in their presence. Novel methodology for testing is given by
Dielenberg and McGregor (1999). Testing chambers comprised of a rectangular arena
with perspex walls (60 cm x 26 cm x 36 cm) and a metal grid
floor which was raised 2 cm above a tray containing wood shavings. At one end of the
chamber was a small wooden box (21 cm x 24 cm x 22 cm) termed the ‘hide box’. On
the front wall of the hide box was a small square hole (6 cm x 6 cm) that allowed rats to
enter the box. On the opposite wall of the apparatus to the hide box was an
alligator clip positioned 4 cm above the metal grid floor. During testing, a piece of cat
collar was attached to the clip as shown in Fig.8. A domestic cat wore this cat
collar for a period of three weeks before the start of the experiment. Photocell
detectors were placed at opposite ends of the chamber. The placement of the
photocells allowed determination of: i) the amount of time the rats
spent in close vicinity to the cat collar (approach time); and ii) the amount of time
spent in the hide box (hide time). During testing, the room in which the chambers
were situated was illuminated by a 40 W red-light suspended
1.5 m above the apparatus.
Vogel punished drinking
 This test is a well-known method used in rats,
designed by Vogel et al.
• Recently, this test has been reported to successfully
detect anxiolytic-like action of diazepam .
 • In this test, thirsty animals gain water reward
through a water spout, but at the expense of receiving a
mild electric shock delivered to the tongue.
 Rats are deprived of water for 48 hrs
 • Then placed in chamber with watersource
 • sprague dawley rats are used in this model
Electric circuit is connected between
drinking tube and floor of cage.
i.p injection of drugs are given; 30min later
rats placed in cage and allowed to drink
water and shock given after 20 licks
For 3minutes next shocks are given for
every 12th lick
No. of shocks delivered in 3min noted for
each animal, no. of shocks received after
treatment noted
a water bottle with metal drinking tube is
fitted to the animal housing
o number of accepted punishments (electric
shock) are measured during conflict period
Anxiolytic effect :
o increase in the accepted shocks.
Apparatus
Clear Plexiglas box (38 x 38 cm) has a steel
grid floor.
A water bottle with metal drinking tube at 3
cm above the
grid.
A circuit is connected b/w the drinking tube
and steel
floor, so that the circuit completes if animal
licks the tube.
Geller seifter conflict (marmoset,
pigeon conflict)
 .
•Conflict is produced by availability of
reinforcement with punishment
• Experimentally induced conflict by punishing
food rewarded behavior has been used to
differentiate between various psychoactive
drugs by Geller and Seifter
• Male albino rats with a body weight of 300–400
g are housed individually.
• They are food deprived until the body weight is
gradually reduced by approximately 20% of
original and it is maintained at this level by
restricted food diet.
• Conditioning is carried out with a flash of light, a
single lever, a liquid dripper, and a grid-floor
connected to a shocker
• The animals are trained to lever press for the milk
reward in two distinct response-reward sections.
• Anxiety or “conflict” segment (3 min)
• a dipper of milk is delivered in response to each
lever press (continuos reinforcement schedule
=CRF),
• accompanied by aversive foot-shock through the
grid floor
• Creates a conflict between milk reward and the a
painful foot shock
“nonconflict” segment (15 min)
• lever presses produce a drop of milk only at variable intervals of time from
60 to 210 s with an average reward of once per 2min
• No shocks are administered
• Four cycles of 15 min nonshock variable interval segments followed by a
three minute CRF-conflict period phase
• The total number of lever presses during the conflict periods (CRF) and the
non-conflict periods (VI) are counted.
• Anxiolytic effect :An increase of lever presses
in the conflict periods
Electric brain stimulation
 • Electrical stimulation of brain aversive areas, in
particular the midbrain central gray, induces defensive
reaction and/or flight behavior in several species
 • Used as an animal model of anxiety or of panic
attack.
 • Most studies used intracerebral microinjections of
neurotransmitters, their agonists and antagonists to
elucidate the mechanisms of aversive or antiaversive
effects
Foot shock induced aggression
 • GABA is involved in control and agrgressive
 behaviour of animals.
 • Benzodiazepines are thought to produce
 anxiolytic effects by binding to a specific high
 affinity site on GABA-A receptor
 • So aggressive and fighting behavior has been
 extended for GABAergic anxiolytic drug
 screening.
The fighting behaviour consists of vocalization, leaping,
running, rearing and facing each other with some attempt to
attack by hitting, biting or boxing
Two mice are placed in a box with a grid floor consisting of
steel rods
A constant current of 0.6 or 0.8mA is supplied to the grid floor
is delivered for 5 s followed by 5 s. intermission for 3 min.
The total number of fights are recorded for each pair during
the 3-min period.
Pathological anxiety
(Neurochemically - induced anxiety)
mCPP - [ 1-(3-chlorphenyl) piperazine] a 5HT 1c
agonist.
o mCPP induces hypophagia and
hypo-locomotion , inhibits social interaction,
diminishes exploratory activity in light-dark
box test, hyper therimia etc,.
o Antagonism of these symptoms is used for
screening of anxiolytic drugs.
Anticipatory anxiety in mice
 Anticipatory anxiety in mice
 • When group housed mice are removed one by one
 from their former cage, the last mice always have
 a higher body temperature than the 1st one.
 • The anticipatory increase in temperature was
 prevented by prior administration of diazepam &
 buspirone
Test drug/solvent administered p.o to all the 18 animals.
Record the basal temp by removing 1st 3 animals/group
after 30 min
Difference in the mean value of last three
animals and basal
value is calculated
Vehicle treated group 1- 1.3˚C
Male Sprague
Dawley rats (200-
250g) are housed in
groups of 6;
exposed to 12 hour
light/dark cycle
with free access to
food and water.
mCPP Induced Anxiety
-Locomotion Study
• Test compound or vehicle are administered orally 1h
or i.p 30 min before the locomotion test.
• mCPP is injected i.p. in a dose of 7 mg/kg 20 min
before the test.
• The animals are placed individually in an automated
locomotor activity cages and locomotion is recorded
for 10 min.
• Anxiolytic effect : disinhibition of locomotion.
Parameters measured :
o time spent in both sides (horizontal,
vertical activity)
o frequency of motion
o number of transition
Anxiolytic effect :
o increase in parameters measured in
the light/dark box or in number of
transitions if test is active.
A method is described for reproducible measurement of ultrasonic
vocalization induced by tail-holding stress in rat pups. The anxiolytic
benzodiazepines, chlordiazepoxide, diazepam, and CL 218872, reduced
the ultrasounds at doses inducing little CNS depressant activity. Gross
behavioral disruption such as sedation (muscimol, prazosin, and
chlorpromazine), tremors (yohimbine), myoclonus (MK212), and
immobility (morphine) resulted in reduction of ultrasounds. Non-
behaviourally active doses of these compound or any doses tested of
mephenesin, amphetamine, amitriptyline, haloperidol, and naloxone did
not affect the ultrasounds. Metergoline inhibited ultrasounds at doses
producing little change in overt behavior. This method is proposed as a
convenient model of anxiety which may also be influenced by central 5-
hydroxytryptamine transmission.
Screening of anxiolytic agents

More Related Content

What's hot

Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugsBindu Pulugurtha
 
Preclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer'sPreclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer's
Drx Burade
 
Screening Methods for behavioural and muscle Coordination
 Screening Methods for behavioural and muscle Coordination Screening Methods for behavioural and muscle Coordination
Screening Methods for behavioural and muscle Coordination
pradnya Jagtap
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
Dr Roohana Hasan
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malik
VikasMalik68
 
Screening models of alzheimer’s disease
Screening models of alzheimer’s disease Screening models of alzheimer’s disease
Screening models of alzheimer’s disease
VishnuPrabhakar26
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
HimikaRathi
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Antidepressants Drugs
Screening Models of Antidepressants DrugsScreening Models of Antidepressants Drugs
Screening Models of Antidepressants Drugs
KomalSingh301
 
Screening Methods of Anti Anxiety Agents
Screening Methods of Anti Anxiety AgentsScreening Methods of Anti Anxiety Agents
Screening Methods of Anti Anxiety Agents
Anupam dubey
 
Screening of antiparkinsonian agents
Screening of antiparkinsonian agentsScreening of antiparkinsonian agents
Screening of antiparkinsonian agents
Dr. Mallappa Shalavadi
 
Preclinical screening methods of Sedative and hypnotics by syed
Preclinical screening methods of Sedative and hypnotics by syedPreclinical screening methods of Sedative and hypnotics by syed
Preclinical screening methods of Sedative and hypnotics by syed
Mubasheer syed
 
Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Divya Krishnan
 
Screening Methods of Parkinson's Disease
Screening Methods of Parkinson's DiseaseScreening Methods of Parkinson's Disease
Screening Methods of Parkinson's Disease
Anupam dubey
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activitySravanthi Shetty
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Abdul Hameed
 
Preclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activityPreclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activity
ShrutiGautam18
 
Screening of antianxiety drugs
Screening of antianxiety drugsScreening of antianxiety drugs
Screening of antianxiety drugs
Kanthlal SK
 
screening model for parkinsons disease
screening model for parkinsons diseasescreening model for parkinsons disease
screening model for parkinsons disease
Kundlik Rathod
 
Anti epileptic screening model
Anti epileptic screening modelAnti epileptic screening model
Anti epileptic screening model
KhushbooThakur15
 

What's hot (20)

Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugs
 
Preclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer'sPreclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer's
 
Screening Methods for behavioural and muscle Coordination
 Screening Methods for behavioural and muscle Coordination Screening Methods for behavioural and muscle Coordination
Screening Methods for behavioural and muscle Coordination
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malik
 
Screening models of alzheimer’s disease
Screening models of alzheimer’s disease Screening models of alzheimer’s disease
Screening models of alzheimer’s disease
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Anti-Atherosclerosis
 
Screening Models of Antidepressants Drugs
Screening Models of Antidepressants DrugsScreening Models of Antidepressants Drugs
Screening Models of Antidepressants Drugs
 
Screening Methods of Anti Anxiety Agents
Screening Methods of Anti Anxiety AgentsScreening Methods of Anti Anxiety Agents
Screening Methods of Anti Anxiety Agents
 
Screening of antiparkinsonian agents
Screening of antiparkinsonian agentsScreening of antiparkinsonian agents
Screening of antiparkinsonian agents
 
Preclinical screening methods of Sedative and hypnotics by syed
Preclinical screening methods of Sedative and hypnotics by syedPreclinical screening methods of Sedative and hypnotics by syed
Preclinical screening methods of Sedative and hypnotics by syed
 
Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan
 
Screening Methods of Parkinson's Disease
Screening Methods of Parkinson's DiseaseScreening Methods of Parkinson's Disease
Screening Methods of Parkinson's Disease
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
Preclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activityPreclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activity
 
Screening of antianxiety drugs
Screening of antianxiety drugsScreening of antianxiety drugs
Screening of antianxiety drugs
 
screening model for parkinsons disease
screening model for parkinsons diseasescreening model for parkinsons disease
screening model for parkinsons disease
 
Anti epileptic screening model
Anti epileptic screening modelAnti epileptic screening model
Anti epileptic screening model
 

Similar to Screening of anxiolytic agents

ANXIOLYTICS.pptx
ANXIOLYTICS.pptxANXIOLYTICS.pptx
ANXIOLYTICS.pptx
AdarshGaur8
 
Anxiolytic screening models_utkarsh
Anxiolytic screening models_utkarshAnxiolytic screening models_utkarsh
Anxiolytic screening models_utkarshUtkarsh Alok
 
Anxiolytic poonam ppt.pptx
Anxiolytic poonam ppt.pptxAnxiolytic poonam ppt.pptx
Anxiolytic poonam ppt.pptx
PoonamJoshi51
 
Anxiolytics screening methods
Anxiolytics screening methodsAnxiolytics screening methods
Anxiolytics screening methods
Dekollu Suku
 
Screening Models of Alzheimers disease.pptx
Screening Models of Alzheimers disease.pptxScreening Models of Alzheimers disease.pptx
Screening Models of Alzheimers disease.pptx
Archna53
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
Dr. Manu Kumar Shetty
 
Nootropics (M.Pharm)
Nootropics (M.Pharm)Nootropics (M.Pharm)
Nootropics (M.Pharm)
Ravindra Saroj
 
Hypnotics Screening Methods by Tarun Biswas
Hypnotics Screening Methods by Tarun BiswasHypnotics Screening Methods by Tarun Biswas
Hypnotics Screening Methods by Tarun Biswas
Tarun Biswas
 
Neuropharmacology: Methods
Neuropharmacology: MethodsNeuropharmacology: Methods
Neuropharmacology: Methods
Brian Piper
 
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsScreening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
MADHAV JAJNURE
 
Screening methods
Screening methodsScreening methods
Screening methods
Maheshwari Hireholi
 
Method of intermittant observations
Method of intermittant observations Method of intermittant observations
Method of intermittant observations
Riya Arora
 
Screening methods for Analgesics
Screening methods for AnalgesicsScreening methods for Analgesics
Screening methods for Analgesics
FoziyaKhan
 
Neuro degenerative disorders
Neuro degenerative disordersNeuro degenerative disorders
Neuro degenerative disorders
Ch. Bhargava krishna
 
Cns stimulants and depressants screening models
Cns stimulants and depressants screening modelsCns stimulants and depressants screening models
Cns stimulants and depressants screening models
DRASHTI PATEL
 
CNS stimulant & depressant models
CNS stimulant & depressant modelsCNS stimulant & depressant models
CNS stimulant & depressant models
dhruvipatel3790
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
Sravani Ganti
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Ch. Bhargava krishna
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
pradnya Jagtap
 

Similar to Screening of anxiolytic agents (20)

ANXIOLYTICS.pptx
ANXIOLYTICS.pptxANXIOLYTICS.pptx
ANXIOLYTICS.pptx
 
Anxiolytic screening models_utkarsh
Anxiolytic screening models_utkarshAnxiolytic screening models_utkarsh
Anxiolytic screening models_utkarsh
 
Animal behavior
Animal behaviorAnimal behavior
Animal behavior
 
Anxiolytic poonam ppt.pptx
Anxiolytic poonam ppt.pptxAnxiolytic poonam ppt.pptx
Anxiolytic poonam ppt.pptx
 
Anxiolytics screening methods
Anxiolytics screening methodsAnxiolytics screening methods
Anxiolytics screening methods
 
Screening Models of Alzheimers disease.pptx
Screening Models of Alzheimers disease.pptxScreening Models of Alzheimers disease.pptx
Screening Models of Alzheimers disease.pptx
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
 
Nootropics (M.Pharm)
Nootropics (M.Pharm)Nootropics (M.Pharm)
Nootropics (M.Pharm)
 
Hypnotics Screening Methods by Tarun Biswas
Hypnotics Screening Methods by Tarun BiswasHypnotics Screening Methods by Tarun Biswas
Hypnotics Screening Methods by Tarun Biswas
 
Neuropharmacology: Methods
Neuropharmacology: MethodsNeuropharmacology: Methods
Neuropharmacology: Methods
 
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsScreening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
 
Screening methods
Screening methodsScreening methods
Screening methods
 
Method of intermittant observations
Method of intermittant observations Method of intermittant observations
Method of intermittant observations
 
Screening methods for Analgesics
Screening methods for AnalgesicsScreening methods for Analgesics
Screening methods for Analgesics
 
Neuro degenerative disorders
Neuro degenerative disordersNeuro degenerative disorders
Neuro degenerative disorders
 
Cns stimulants and depressants screening models
Cns stimulants and depressants screening modelsCns stimulants and depressants screening models
Cns stimulants and depressants screening models
 
CNS stimulant & depressant models
CNS stimulant & depressant modelsCNS stimulant & depressant models
CNS stimulant & depressant models
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
 

Recently uploaded

Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 

Recently uploaded (20)

Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 

Screening of anxiolytic agents

  • 1. Presented by: Yasmeen Mir M. Pharm ist year (Pharmacology-İII) Roll no.:18155110001
  • 2. Anxiety Disorders  Definition : Anxiety is a condition of persistent and uncontrollable nervousness, stress, and worry, triggered by anticipation of future events, memories of past events, or ruminations over day- to-day events, with disproportionate fears of catastrophic consequences.  It is characterized by feelings of apprehension, insecurity, uncertainty or fear.
  • 3.  Generalized Anxiety Disorder(Excessive, unrealistic worry that lasts six months or more)  Obsessive-Compulsive Disorder (Persistent, recurring thoughts or obsessions that reflect exaggerated anxiety or fears )  Post-Traumatic Stress Disorder ( Exposure to a traumatic event) Panic Disorders (Severe attacks of panic for no apparent reason)  Phobias (Extreme anxiety about being judged by others, or intense fear reaction to a specific object or situation such as spiders, dogs, or Acrophobia). Types of anxiety
  • 4. Preclinical anxiety models  The goal of anxiety models is to produce a form of abnormally elevated anxiety.  It should more closely resemble, by definition, the pathological nature of human anxiety disorders.  Anxiety models are Models that generate lasting or permanently heightened anxiety.  This can be achieved by acutely or chronically subjecting animals to stressors before testing.  OR identifying genetic populations (inbred and selectively bred strains) or engineering mutant mice with innate anxiety-like phenotypes.
  • 5. This approach has proven to be valuable for screening novel anxiolytics and testing the pharmacoselectivity of putative anxiolytics . Emerging genetic technology is the optogenetics. It will be integral to future basic anxiety research. optogenetics is the combination of genetic and optical methods to control specific events in targeted cells of living tissue in the millisecond timescale. Optogenetic approaches have been used to map neural circuits in the amygdala that contribute to fear conditioning.
  • 6. PRECLINICAL EVALUATION OF ANXIOLYTICS In-vitro Methods: 1. GABA receptor binding 2. Benzodiazepine receptor: [3H]-flunitrazepam binding assay 3. Serotonin (5-HT1A) receptor: binding of [3H]-8-hydroxy- 2-(di-n-propylamino)-tetralin ([3H]-DPAT) 4. Serotonin (5-HT1B) receptors in brain: binding of [3H]5- hydroxytryptamine ([3H]5-HT)
  • 7. The following parameters are calculated: • Total binding • Non-specific binding •Specific binding= total binding– non-specific binding.
  • 8.  In Vivo Methods  Methods based on unconditioned (spontaneous) response:  Exploratory activity  Elevated plus-maze (other Mazes such as Y, X,T, Radial, water and Zero Maze)  Open field/Closed field  Light-dark model (two compartment box)  Staircase exploration  Hole board test  Mirror chamber test  Social behavior  Social interaction  Isolation induced aggression  Anticipatory anxiety in mice  Predator  Defense test battery in rats  Human threat (Primates)  Odor associated avoidance behavior  Others  Novelty suppressed feeding  Schedule induced polydipsia in rats  Marble burying  Cork gnawing  Stress induced hyperthermia
  • 9. • Methods based on conditioned (learned) response: Punishment models: • Four plate test • Punishment induced operant behavior • Conditioned emotional response Conflict models: • Vogel punished drinking • Geller seifter conflict (marmoset, pigeon conflict) • Shock probe conflict procedure Respondent conditioned with aversion stimuli: • Conditioned suppression • Potentiated startle response • Electric brain stimulation Frustration (non-reward) test: • Shock probe- burying test
  • 10. In Vivo Methods Validity • Face validity : A feature that is assessed (for a test or model of anxiety) by determining how closely the model or test resembles human anxiety symptoms. • Predictive validity : whether the model or test reliably responds to clinically efficacious anti- anxiety medications. • Construct validity : whether the degree to which the model or test recruits the same underlying neurobiology as implicated in human anxiety.
  • 11. Elevated Plus Maze Test For selective identification of anxiolytics and anxiogenic drugs Anxiolytics –decrease anxiety – increase open arm exploration time. Anxiogenics – decrease open arm exploration time. Most widely used method; male mice/rats used.
  • 12. Experimental Design • Group I : control • Group II : standard • Group III : test treated with dose x • Group IV : test treated with dose 2x ….
  • 13. The rats weighing around 200g - housed in pairs for 10 days prior to testing; 6animals selected for each group. Test drug administered 30min prior to experimentation by i.p route. The rat is then placed in the centre of the maze facing one of the enclosed arms. Animals were allowed to explore in the maze for 5 min. Observations will done from adjacent room via remote TV camera.
  • 14. Parameters Measured During Next 5 minutes: o time spent in the open arms o entries into the open arms o time spent in the closed arms o entries into the closed arms o total arm entries
  • 15. Evaluation of results: o Motor activity and open arm exploratory activity determined. o Values of treated groups expressed as % of control values. o Benzodiazepines and valproate – decrease motor activity increase exploratory time. Anxiolytic effect indicated by: o Increase in the proportion of time spent in open arms. o Increase in the proportion of entries into open arms.
  • 16. Open-field Test  This test, originally designed by Hall on rats.  It consists of placing an animal in an unknown environment with surrounding walls, so as to observe a number of behavior patterns, including:  The tendency to stay on the periphery of the field without entering the centre (called thigmotaxis and often interpreted as anxious behavior)  level of defecation and urination.
  • 17. Anxiolytic agents should lead to increase in this ratio.  The open field floor is divided into squares  Animals are tested individually, always being placed in the same position.  Duration of test is usually 5 min. Higher levels of anxiety should mainly lead to decreases in the ratio ‘number of squares visited in centre/number of squares visited on periphery.
  • 18. Light – dark model • Crawley and Goodwin (1980). • Mice and rats tend to explore novel environment ,but retreat from brightly- lit open field.
  • 19. In a two chambered system, where animal can freely move between brightly lit open field and dark corner, they show more crossings between two chambers and more locomotor activity after treatment with anxiolytics. Methodology • Test apparatus- light and dark chamber divided by photocell equipped zone. • Polypropylene animal cage 44x21x21 cm, darkened with black spray over on- third of surface. • Partition containing 13cm long x 5cm high opening separates the dark one third from bright two thirds of the cage • Cage rests on an animex activity monitor, which counts the locomotor activity. • Four sets of photocells across the partition, automatically counts movement through the partition and clocks time spent in light and dark
  • 20. Male mice with a weight between 18 and 24 g are used Test drug administered 30min prior to experimentation by i.p. route. The animal is placed in the cage and observed for 10 min.
  • 21. Observation o No. Of crossings through the partition between the light and dark chambers compared with total activity counts during the 10 min. o Loco motor activity also monitored. Evaluation: o Anxiolytics like diazepam & buspirone increase locomotor activity and no. Of crossings. o Non anxiolytics - not effective in this model.
  • 23. • When introduced into a novel environment, rodents experience a conflict between anxiety and exploratory behavior manifested by increased vigilance and behavioral activity • Staircase climibing reflects exploratory or locomotor activity • Rearing behavior is an index of anxiety state • The no. of rearing and steps climbed to be recorded for period of 5 minutes • Decrease in rearing behavior and increase in steps climbed is characterization of anxiolytic effect
  • 24. Male mice (Charles River strain) with a weight between 18 and 24 g are used Test drug administered 30min prior to experimentation by s.c. route. The animal is placed on the floor of the box with its back to the staircase.(staircase is composed of five identical steps 2.5 cm high, 10 cm wide )
  • 25. Mirrored chamber test Novel stimulation evokes both exploration and anxiety and therefore generates approach avoidance conflict behaviour • It is hypothesised that distortion of readily traversed environment by a chamber of mirror might produce aversion to entry • Mice are exposed to the chamber of mirror • Extended latency to enter the chamber of mirror used as a parameter for anxiety analogy • Anxiolytics reduce this latency in dose dependent manner.
  • 26.
  • 27. Social interaction in rats • Purpose and rationale : In an unfamiliar and brightly lit environment, the normal social interaction of rats ( sniffing, nipping, grooming) is suppressed. • Anxiolytics counteract this suppression.
  • 28. Animals placed in groups of 5 each in a perspex open topped box 1hr before test,2 rats from separate housing treated with test compound orally Placed in box with 60W bulb and behavior observed for 10minutes social interactions like sniffing, rearing, crawling over the partner are observed
  • 29. Procedure: • Male sprague-dawley rats (225-275g) are housed in groups of 5 animals • Apparatus: perspex open-topped box (51x51x 20cm) with 17x17cm marked areas on the floor. • One hour prior to the test, 2 naïve rats from separate housing cages are treated with test compound orally • They are placed into the box (with 60W bright illumination 17cm above) and their behaviour is observed over a 10 min period. • 2 types of behaviour can be noted: • Social interaction between the animals is determined by timing the sniffing of partner, crawling under or climbing over partner and following partner.
  • 30. • Exploratory motion is measured as the number of crossings of the lines marked on the floor of the test box. • Six pairs are used for each dose • Evaluation: values of treated partners are compared with the data from 6 pairs of untreated animals using single factor analysis of variance followed by Dunnett’s test
  • 31. Isolation induced aggression o Male mice subjected to isolation Develop aggressive behavior towards other animals of same sex.
  • 32. Male Mice kept isolated for 6weeks & aggressive behavior tested. Male mice accustomed to live together placed in cage of isolated mice for 5minutes Isolated mice attacks intruder aggressiveness observed Drugs given to isolated mice s.c or orally; aggressive behavior tested at 60, 120,240 minutes (oral route) If drug active- decrease in aggressiveness Attenuation of fighting reaction
  • 33. Human threat (primates): Suarez and Gallup (1982) first demonstrated human being as a predator. It can be studied in various ways of avoidance of experimenter. One method involves an experimenter sitting in a chair in the center of a floor containing chicks. The proximity of the chicks to the human is then determined usually by numbering imaginary zones around the occupied chair. The chicks are then given an ‘avoidance score’ of 1-5 (either in ascending or descending proximity to the experimenter) based on a total of their positions over a certain time frame. Another method is called the ‘box plus experimenter’ method. This test uses the same premise as the above method; however, during the box plus experimenter test, the human is seated behind a wire mesh wall at the end of an arena. The chick is scored on its approach or avoidance to the experimenter behaviors. Again, higher avoidance suggests higher fear levels.
  • 34. Odour associated avoidance behaviour: The predatory odour avoidance model relies upon the apparently innate fear that rodents have for the odor of their natural predators, such as cats and foxes. Rats tend to avoid such odors and engage in a variety of defensive behaviours in their presence. Novel methodology for testing is given by Dielenberg and McGregor (1999). Testing chambers comprised of a rectangular arena with perspex walls (60 cm x 26 cm x 36 cm) and a metal grid floor which was raised 2 cm above a tray containing wood shavings. At one end of the chamber was a small wooden box (21 cm x 24 cm x 22 cm) termed the ‘hide box’. On the front wall of the hide box was a small square hole (6 cm x 6 cm) that allowed rats to enter the box. On the opposite wall of the apparatus to the hide box was an alligator clip positioned 4 cm above the metal grid floor. During testing, a piece of cat collar was attached to the clip as shown in Fig.8. A domestic cat wore this cat collar for a period of three weeks before the start of the experiment. Photocell detectors were placed at opposite ends of the chamber. The placement of the photocells allowed determination of: i) the amount of time the rats spent in close vicinity to the cat collar (approach time); and ii) the amount of time spent in the hide box (hide time). During testing, the room in which the chambers were situated was illuminated by a 40 W red-light suspended 1.5 m above the apparatus.
  • 35.
  • 36. Vogel punished drinking  This test is a well-known method used in rats, designed by Vogel et al. • Recently, this test has been reported to successfully detect anxiolytic-like action of diazepam .  • In this test, thirsty animals gain water reward through a water spout, but at the expense of receiving a mild electric shock delivered to the tongue.  Rats are deprived of water for 48 hrs  • Then placed in chamber with watersource  • sprague dawley rats are used in this model
  • 37. Electric circuit is connected between drinking tube and floor of cage. i.p injection of drugs are given; 30min later rats placed in cage and allowed to drink water and shock given after 20 licks For 3minutes next shocks are given for every 12th lick No. of shocks delivered in 3min noted for each animal, no. of shocks received after treatment noted a water bottle with metal drinking tube is fitted to the animal housing
  • 38. o number of accepted punishments (electric shock) are measured during conflict period Anxiolytic effect : o increase in the accepted shocks. Apparatus Clear Plexiglas box (38 x 38 cm) has a steel grid floor. A water bottle with metal drinking tube at 3 cm above the grid. A circuit is connected b/w the drinking tube and steel floor, so that the circuit completes if animal licks the tube.
  • 39. Geller seifter conflict (marmoset, pigeon conflict)  . •Conflict is produced by availability of reinforcement with punishment • Experimentally induced conflict by punishing food rewarded behavior has been used to differentiate between various psychoactive drugs by Geller and Seifter • Male albino rats with a body weight of 300–400 g are housed individually. • They are food deprived until the body weight is gradually reduced by approximately 20% of original and it is maintained at this level by restricted food diet. • Conditioning is carried out with a flash of light, a single lever, a liquid dripper, and a grid-floor connected to a shocker • The animals are trained to lever press for the milk reward in two distinct response-reward sections.
  • 40. • Anxiety or “conflict” segment (3 min) • a dipper of milk is delivered in response to each lever press (continuos reinforcement schedule =CRF), • accompanied by aversive foot-shock through the grid floor • Creates a conflict between milk reward and the a painful foot shock “nonconflict” segment (15 min) • lever presses produce a drop of milk only at variable intervals of time from 60 to 210 s with an average reward of once per 2min • No shocks are administered • Four cycles of 15 min nonshock variable interval segments followed by a three minute CRF-conflict period phase • The total number of lever presses during the conflict periods (CRF) and the non-conflict periods (VI) are counted. • Anxiolytic effect :An increase of lever presses in the conflict periods
  • 41. Electric brain stimulation  • Electrical stimulation of brain aversive areas, in particular the midbrain central gray, induces defensive reaction and/or flight behavior in several species  • Used as an animal model of anxiety or of panic attack.  • Most studies used intracerebral microinjections of neurotransmitters, their agonists and antagonists to elucidate the mechanisms of aversive or antiaversive effects
  • 42. Foot shock induced aggression  • GABA is involved in control and agrgressive  behaviour of animals.  • Benzodiazepines are thought to produce  anxiolytic effects by binding to a specific high  affinity site on GABA-A receptor  • So aggressive and fighting behavior has been  extended for GABAergic anxiolytic drug  screening.
  • 43. The fighting behaviour consists of vocalization, leaping, running, rearing and facing each other with some attempt to attack by hitting, biting or boxing Two mice are placed in a box with a grid floor consisting of steel rods A constant current of 0.6 or 0.8mA is supplied to the grid floor is delivered for 5 s followed by 5 s. intermission for 3 min. The total number of fights are recorded for each pair during the 3-min period.
  • 44. Pathological anxiety (Neurochemically - induced anxiety) mCPP - [ 1-(3-chlorphenyl) piperazine] a 5HT 1c agonist. o mCPP induces hypophagia and hypo-locomotion , inhibits social interaction, diminishes exploratory activity in light-dark box test, hyper therimia etc,. o Antagonism of these symptoms is used for screening of anxiolytic drugs.
  • 45.
  • 46. Anticipatory anxiety in mice  Anticipatory anxiety in mice  • When group housed mice are removed one by one  from their former cage, the last mice always have  a higher body temperature than the 1st one.  • The anticipatory increase in temperature was  prevented by prior administration of diazepam &  buspirone
  • 47. Test drug/solvent administered p.o to all the 18 animals. Record the basal temp by removing 1st 3 animals/group after 30 min Difference in the mean value of last three animals and basal value is calculated Vehicle treated group 1- 1.3˚C
  • 48. Male Sprague Dawley rats (200- 250g) are housed in groups of 6; exposed to 12 hour light/dark cycle with free access to food and water.
  • 49. mCPP Induced Anxiety -Locomotion Study • Test compound or vehicle are administered orally 1h or i.p 30 min before the locomotion test. • mCPP is injected i.p. in a dose of 7 mg/kg 20 min before the test. • The animals are placed individually in an automated locomotor activity cages and locomotion is recorded for 10 min. • Anxiolytic effect : disinhibition of locomotion.
  • 50. Parameters measured : o time spent in both sides (horizontal, vertical activity) o frequency of motion o number of transition Anxiolytic effect : o increase in parameters measured in the light/dark box or in number of transitions if test is active.
  • 51. A method is described for reproducible measurement of ultrasonic vocalization induced by tail-holding stress in rat pups. The anxiolytic benzodiazepines, chlordiazepoxide, diazepam, and CL 218872, reduced the ultrasounds at doses inducing little CNS depressant activity. Gross behavioral disruption such as sedation (muscimol, prazosin, and chlorpromazine), tremors (yohimbine), myoclonus (MK212), and immobility (morphine) resulted in reduction of ultrasounds. Non- behaviourally active doses of these compound or any doses tested of mephenesin, amphetamine, amitriptyline, haloperidol, and naloxone did not affect the ultrasounds. Metergoline inhibited ultrasounds at doses producing little change in overt behavior. This method is proposed as a convenient model of anxiety which may also be influenced by central 5- hydroxytryptamine transmission.